HER2-low-positive breast cancer from four neoadjuvant clinical trials

Abeid Omar¹, Waleed Arafat²

Affiliations

¹ Department of Clinical Oncology, Alexandria University, Alexandria 21131, Egypt.
² Department of Clinical Oncology, Alexandria University, Alexandria 21131, Egypt. Electronic address: waleed.arafat@alexmed.edu.eg.

PMID: 34592187
DOI: 10.1016/S1470-2045(21)00456-3

Comment

HER2-low-positive breast cancer from four neoadjuvant clinical trials

Abeid Omar et al. Lancet Oncol. 2021 Oct.

. 2021 Oct;22(10):e426.

doi: 10.1016/S1470-2045(21)00456-3.

Authors

Abeid Omar¹, Waleed Arafat²

Affiliations

¹ Department of Clinical Oncology, Alexandria University, Alexandria 21131, Egypt.
² Department of Clinical Oncology, Alexandria University, Alexandria 21131, Egypt. Electronic address: waleed.arafat@alexmed.edu.eg.

PMID: 34592187
DOI: 10.1016/S1470-2045(21)00456-3

No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment in

HER2-low-positive breast cancer from four neoadjuvant clinical trials - Authors' reply.
Denkert C, Nekljudova V, Loibl S. Denkert C, et al. Lancet Oncol. 2021 Oct;22(10):e427. doi: 10.1016/S1470-2045(21)00548-9. Lancet Oncol. 2021. PMID: 34592188 No abstract available.

Comment on

Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
Denkert C, Seither F, Schneeweiss A, Link T, Blohmer JU, Just M, Wimberger P, Forberger A, Tesch H, Jackisch C, Schmatloch S, Reinisch M, Solomayer EF, Schmitt WD, Hanusch C, Fasching PA, Lübbe K, Solbach C, Huober J, Rhiem K, Marmé F, Reimer T, Schmidt M, Sinn BV, Janni W, Stickeler E, Michel L, Stötzer O, Hahnen E, Furlanetto J, Seiler S, Nekljudova V, Untch M, Loibl S. Denkert C, et al. Lancet Oncol. 2021 Aug;22(8):1151-1161. doi: 10.1016/S1470-2045(21)00301-6. Epub 2021 Jul 9. Lancet Oncol. 2021. PMID: 34252375

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

HER2-low-positive breast cancer from four neoadjuvant clinical trials

Affiliations

HER2-low-positive breast cancer from four neoadjuvant clinical trials

Authors

Affiliations

Conflict of interest statement

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Research Materials

Miscellaneous